We are live on ! Find out more
CG

Carmignac Gestion Portfolio holdings

AUM $6.51B
1-Year Est. Return 19.13%
This Fund
S&P 500
This Quarter Est. Return
+13.27%
1 Year Est. Return
+19.13%
3 Year Est. Return
+94.32%
5 Year Est. Return
+115.43%
10 Year Est. Return
+608.92%
AUM
$5.54B
AUM Growth
+$883M
Cap. Flow
+$368M
Cap. Flow %
6.64%
Top 10 Hldgs %
44.52%
Holding
154
New
27
Increased
59
Reduced
33
Closed
19

Top Buys

1
BABA icon
Alibaba
BABA
+$243M
2
SYK icon
Stryker
SYK
+$161M
3
AMD icon
Advanced Micro Devices
AMD
+$138M
4
BEKE icon
KE Holdings
BEKE
+$117M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$81.5M

Top Sells

1
AMZN icon
Amazon
AMZN
+$231M
2
SLB icon
SLB Ltd
SLB
+$158M
3
CTLT
CATALENT, INC.
CTLT
+$128M
4
CRM icon
Salesforce
CRM
+$71M
5
COST icon
Costco
COST
+$65.3M

Sector Composition

1 Healthcare 22.83%
2 Technology 20.78%
3 Consumer Discretionary 16.78%
4 Financials 10.4%
5 Materials 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BABA icon
1
Alibaba
BABA
$282B
$319M 5.75%
3,615,798
+3,086,382
+583% +$243M
MSFT icon
2
Microsoft
MSFT
$2.98T
$305M 5.5%
1,269,744
+26,487
+2% +$6.36M
ORCL icon
3
Oracle
ORCL
$358B
$282M 5.09%
3,448,996
+645,148
+23% +$49M
SLB icon
4
SLB Ltd
SLB
$70.4B
$264M 4.76%
4,930,846
-3,163,634
-39% -$158M
SPGI icon
5
S&P Global
SPGI
$135B
$238M 4.3%
711,372
+104,436
+17% +$34.4M
ELV icon
6
Elevance Health
ELV
$80.9B
$231M 4.17%
449,539
-29,585
-6% -$15M
LLY icon
7
Eli Lilly
LLY
$1.04T
$228M 4.11%
622,030
-81,702
-12% -$29M
SYK icon
8
Stryker
SYK
$127B
$213M 3.84%
870,509
+709,371
+440% +$161M
DHR icon
9
Danaher
DHR
$145B
$195M 3.51%
826,945
-87,658
-10% -$20.3M
JD icon
10
JD.com
JD
$40.1B
$192M 3.47%
3,426,035
-1,046,010
-23% -$52.6M
ICE icon
11
Intercontinental Exchange
ICE
$80.2B
$184M 3.33%
1,796,499
+72,578
+4% +$7.23M
AEM icon
12
Agnico Eagle Mines
AEM
$68.6B
$156M 2.83%
3,008,838
+626,759
+26% +$29.6M
HUM icon
13
Humana
HUM
$46.4B
$144M 2.6%
281,329
-9,579
-3% -$5.03M
B
14
Barrick Mining
B
$58.4B
$138M 2.49%
8,035,293
+1,917,071
+31% +$30.5M
AMD icon
15
Advanced Micro Devices
AMD
$817B
$136M 2.46%
2,102,028
+2,090,028
+17,417% +$138M
BEKE icon
16
KE Holdings
BEKE
$19.3B
$135M 2.43%
9,653,732
+8,419,143
+682% +$117M
NEM icon
17
Newmont
NEM
$97B
$132M 2.38%
2,794,100
+789,881
+39% +$35.3M
ORLY icon
18
O'Reilly Automotive
ORLY
$71.5B
$125M 2.27%
2,230,305
-649,110
-23% -$34.9M
TMUS icon
19
T-Mobile US
TMUS
$209B
$120M 2.16%
855,863
-202,672
-19% -$29.1M
CNC icon
20
Centene
CNC
$31.5B
$110M 1.99%
1,340,926
+132,811
+11% +$10.8M
PANW icon
21
Palo Alto Networks
PANW
$289B
$103M 1.86%
1,476,756
-558,324
-27% -$44.8M
BMRN icon
22
BioMarin Pharmaceuticals
BMRN
$11.6B
$89.9M 1.62%
+868,612
New +$81.5M
STZ icon
23
Constellation Brands
STZ
$23.2B
$83M 1.5%
358,256
+67,732
+23% +$16.2M
MA icon
24
Mastercard
MA
$487B
$82M 1.48%
235,830
-831
-0.4% -$274K
HD icon
25
Home Depot
HD
$347B
$75.4M 1.36%
238,580
+30,151
+14% +$9.18M
1
2 3 4 5

Similar funds

TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return
RCWMU
Rothschild & Co Wealth Management (UK) London, United Kingdom $6.53B AUM 0.87% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $6.46B AUM 18.45% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Carmignac Gestion's Q4 2022 Portfolio in Review

As of Q4 2022, Carmignac Gestion held 154 positions worth $5.54B, up 19% from $4.65B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Carmignac Gestion deployed $368M of net new capital in Q4 2022, opening 27 new positions and adding to 59 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 868,612 shares worth $89.9M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Amazon, an estimated $231M trimmed.

  • Carmignac Gestion's largest Q4 2022 buy was BioMarin Pharmaceuticals: 868,612 shares worth $89.9M.
  • Carmignac Gestion added most to Alibaba in Q4 2022, an estimated $243M increase.
  • Carmignac Gestion's biggest Q4 2022 reduction was Amazon, cutting an estimated $231M.
  • Carmignac Gestion fully exited CATALENT, INC. in Q4 2022, selling an estimated $128M.
  • Carmignac Gestion's ten largest holdings make up 45% of its $5.54B portfolio in Q4 2022.
  • Carmignac Gestion opened 27 new positions and closed 19 in Q4 2022.
  • Carmignac Gestion's portfolio value rose 19% quarter-over-quarter to $5.54B.

Based on Carmignac Gestion's 13F filing for Q4 2022, filed 13 Feb 2023.